2023

• Mitra, S., Kroeger, C., Xu, J., Avery, L., Masedunskas, A., Cassidy, S., Wang, T., Hunyor, I., Wilcox, I., Huang, R., Fontana, L., et al (2023). Testing the Effects of App-Based Motivational Messages on Physical Activity and Resting Heart Rate Through Smartphone App Compliance in Patients With Vulnerable Coronary Artery Plaques: Protocol for a Microrandomized Trial. JMIR Research Protocols, 12, | e46082. [More Information]

2022

• Cassidy, S., Hunyor, I., Wilcox, I., Fontana, L. (2022). Changing the conversation from 'chronic disease' to 'chronic health'. European Heart Journal, 43(8), 708-711. [More Information]
• Cassidy, S., Kroeger, C., Wang, T., Mitra, S., Liu, C., Ribeiro, R., Dai, A., Lau, J., Huang, R., Masedunkas, A., Jose, S., Liu, N., McGrady, M., Lo, S., George, J., Cistulli, P., Khor, L., Kozor, R., Ugander, M., Wilcox, I., Hunyor, I., Fontana, L., et al (2022). Impact of an intensive lifestyle program on low attenuation plaque and myocardial perfusion in coronary heart disease: A randomised clinical trial protocol. Nutrition and Healthy Aging, 7(1-2), 9-22. [More Information]

2021

• Milross, M., Norman, M., Wilson, M., Baker, G., Wilcox, I., Sullivan, C. (2021). Measurement of crackles during sleep may have a role to play in titration of positive airway pressure (PAP) modalities in heart failure. Sleep Medicine: X, 3, 100034. [More Information]
• Dutta, S., Li, D., Wang, A., Ishak, M., Cook, K., Farnham, M., Dissanayake, H., Cistulli, P., Hunyor, I., Liu, R., Wilcox, I., Koay, Y., Yang, J., Lal, S., O'Sullivan, J. (2021). Metabolite signatures of heart failure, sleep apnoea, their interaction, and outcomes in the community. ESC Heart Failure, 8(6), 5392-5402. [More Information]

2020

• Wang, N., Fulcher, J., Abeysuriya, N., Park, L., Kumar, S., Di Tanna, G., Wilcox, I., Keech, A., Rodgers, A., Lal, S. (2020). Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327037 participants. The Lancet Diabetes & Endocrinology, 8(1), 36-49. [More Information]

2019

• Rozestraten, F., Wilcox, I., Lalande, S., Simmons, L. (2019). A case report: Mechanical mitral valve thrombosis in pregnancy. European Heart Journal - Case Reports, 3(1), 1-5. [More Information]
• Wang, N., Fulcher, J., Abeysuriya, N., McGrady, M., Wilcox, I., Celermajer, D., Lal, S. (2019). Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. European Heart Journal, 40(5), 476-484. [More Information]

2017

• McDonald, K., O'Hanlon, R., Savage, H., Cowie, M., Khushaba, R., Colefax, M., Farrugia, S., Javed, F., Schindhelm, K., Wilcox, I. (2017). Sleep-disordered breathing in chronic heart failure is highly variable when measured remotely using a novel non-contact biomotion sensor. European Journal of Heart Failure, 19(5), 688-690. [More Information]

2016

• Chan, K., McGrady, M., Wilcox, I. (2016). A leadless intracardiac transcatheter pacing system. New England Journal of Medicine, 374(26), 2604-2605. [More Information]

2014

• Chan, K., Wilcox, I. (2014). Cardiovascular consequences of sleep apnoea: beyond its respiratory manifestations. Cardiology Today, 4(1), 16-21.
• Wilcox, I., Chan, K., Dimitri, H. (2014). Diagnosis and treatment of obstructive sleep apnea is key to achieving optimal results after catheter ablation of atrial fibrillation. Journal of the American College of Cardiology, 63(6), 607-608. [More Information]

2013

• Fulcher, J., Wilcox, I. (2013). Basal stress cardiomyopathy induced by exogenous catecholamines in younger adults. International Journal of Cardiology, 168(6), e158-e160. [More Information]

2012

• Arnott, C., Wilcox, I., Patel, S. (2012). A Case of ST Elevation Myocardial Infarction Secondary to Heparin-induced Thrombocytopaenia with Thrombosis. Heart, Lung, and Circulation, 21(12), 841-843. [More Information]

2011

• Wilcox, I., Chan, K., Lattimore, J. (2011). Hypoxia and inflammation. New England Journal of Medicine, 364(20), 1976-1977. [More Information]

2010

• Wilcox, I. (2010). Cardiovascular Consequences of Obesity. In Peter G Kopelman, William H Dietz and Ian Caterson (Eds.), Clinical Obesity in Adults and Children (third edition), (pp. 228-239). United States: John Wiley & Sons. [More Information]
• Chan, K., Wilcox, I. (2010). Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Review of Cardiovascular Therapy, 8(7), 981-994. [More Information]

2009

• Wilcox, I., Semsarian, C. (2009). Obstructive sleep apnea a respiratory syndrome with protean cardiovascular manifestations. Journal of the American College of Cardiology, 54(19), 1810-1812. [More Information]

2008

• Lattimore, J., Wilcox, I., Adams, M., Kilian, J., Celermajer, D. (2008). Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. International Journal of Cardiology, 126, 229-233. [More Information]

2007

• Willson, G., Grunstein, R., Kirjavainen, T., Young, I., Piper, A., Sullivan, C., Wilcox, I. (2007). Electroencephalographic arousals during sleep do not alter the pressor response to Cheyne-Stokes respiration in subjects with chronic heart failure. Journal of Sleep Research, 16(4), 421-427. [More Information]

2006

• Wilcox, I., Booth, V., Lattimore, J. (2006). Sleep apnea and heart disease. New England Journal of Medicine, 354(10), 1086-9. [More Information]
• Lattimore, J., Wilcox, I., Skilton, M., Langenfeld, M., Celermajer, D. (2006). Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax, 61(6), 491-495. [More Information]

2005

• Wilcox, I. (2005). Cardiovascular consequences of obesity. In Kopelman PG Caterson ID, Dietz WH (Eds.), Clinical Obesity, (pp. 269-280). Melbourne: Blackwell Publishers.
• Lattimore, J., Wilcox, I., Nakhla, S., Langenfeld, M., Jessup, W., Celermajer, D. (2005). Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis, 179(2), 255-259. [More Information]

2003

• Lattimore, J., Celermajer, D., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology, 41(9), 1429-1437. [More Information]

2001

• Willson, G., Wilcox, I., Norman, M., Grunstein, R., Sullivan, C., Piper, A., Flynn, W. (2001). Noninvasive pressure ventilation for the treatment of Cheyne-Stokes respiration during sleep. European Respiratory Journal, 17, 1250-1257. [More Information]

2000

• Loadsman, J., Wilcox, I. (2000). Is obstructive sleep apnoea a rapid eye movement-predoninant phenomenon? British Journal of Anaesthesia, 85, 354-358.